P/E ratio for Lannett Company (LCI)
P/E ratio as of May 2024 (TTM): -0.0271
According to Lannett Company's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.0271163. At the end of 2022 the company had a P/E ratio of -0.1103.
P/E ratio history for Lannett Company from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.1103 | -50.65% |
| 2021 | -0.2234 | -82.14% |
| 2020 | -1.25 | -98.44% |
| 2019 | -80.2 | 11668.62% |
| 2018 | -0.6813 | -103.85% |
| 2017 | 17.7 | -150.6% |
| 2016 | -35.0 | -381.78% |
| 2015 | 12.4 | 3.12% |
| 2014 | 12.0 | |
| 2012 | 16.0 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.6 | -39,182.03% | 🇺🇸 USA |
 Novartis NVS | 26.0 | -96,012.79% | 🇨🇭 Switzerland |
 Pfizer PFE | 15.0 | -55,238.79% | 🇺🇸 USA |
 Abbott Laboratories ABT | 35.6 | -131,497.72% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 12.4 | -45,924.84% | 🇬🇧 UK |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.